Volato Group Secures \$2.2 Million Strategic Investment, Accelerates AI Infrastructure Strategy
Key Investment to Support AI Expansion and Enhance Shareholder Value
ATLANTA, GA – June 8, 2026: Volato Group, Inc. (NYSE American: SOAR) has announced the signing of a definitive agreement for a \$2.2 million strategic investment, led by Catheter Precision, Inc. (NYSE American: VTAK) and supported by other institutional investors specializing in artificial intelligence (AI) and emerging technologies.
Key Points for Investors
- Strategic Investment: The deal involves the issuance of restricted common stock, which will directly strengthen Volato’s balance sheet and support its renewed strategic focus on AI infrastructure, software, data, compute, and power generation sectors.
- AI-Centric Growth: Proceeds from this investment will be used to evaluate and potentially acquire or merge with companies in the AI infrastructure ecosystem, including opportunities in data center infrastructure and power generation assets tailored for AI workloads.
- Pending Closing Conditions: The transaction is subject to customary closing conditions, including approval of a supplemental listing application with the NYSE American stock exchange.
- Recent Strategic Pivot: The investment follows Volato’s termination of a previously announced transaction with M2i Global, a move that Volato’s management believes does not impact its ability to achieve milestones under its NYSE American compliance plan.
- Unsolicited Acquisition Interest: Volato has received two non-binding letters of intent from parties interested in AI infrastructure and power generation sectors, signaling strong market interest in the company’s new direction. However, no definitive agreements have been signed.
- AI Technology Base: Volato already owns Parslee, an AI software platform focused on deterministic document intelligence, and is developing Volato AI to create specialized AI agents for the aviation industry, leveraging its operational expertise and existing technology assets.
- Shareholder Alignment: Catheter Precision, now Volato’s largest shareholder, has expressed strong support for the company’s AI-focused strategy and public market access.
Potential Implications for Shareholders
- Possible Share Price Impact: The strategic investment and shift to AI infrastructure are potentially price-sensitive developments. The company’s efforts to pursue acquisitions or mergers in high-growth AI sectors and interest from strategic investors could drive future share price appreciation, especially if definitive agreements materialize.
- Strategic Direction: The focus on AI infrastructure and software marks a significant pivot for Volato, positioning it in sectors with robust market growth and investor interest.
- Regulatory and Market Risks: The investment and any future transactions are subject to various regulatory, market, and operational risks. There is no guarantee that any acquisition or merger will be completed, and the company may face challenges in maintaining NYSE American listing compliance.
- Balance Sheet Strength: The new investment provides additional financial flexibility as Volato evaluates further strategic transactions.
Management Commentary
“The termination of the M2i transaction gives us the opportunity to refocus on a market opportunity we believe is more closely aligned with Volato’s technology assets, public-company platform, and long-term shareholder value,” said Matt Liotta, Chief Executive Officer of Volato. “We already own and operate an AI software company through Parslee, and we are now actively evaluating opportunities in AI infrastructure. This investment was made after we communicated our AI-focused strategy, and we believe that is an important signal. These investors are backing our future direction, strengthening our balance sheet, and providing additional flexibility as we evaluate acquisition targets and strategic transactions in the AI infrastructure sector.”
“We are excited to support Volato as its now largest shareholder as it executes on its AI strategy,” said David Jenkins, Chief Executive Officer of Catheter Precision. “We believe the Company possesses a unique combination of AI technology assets, industry expertise, and public market access. We look forward to supporting management as it pursues opportunities in the rapidly evolving AI sector.”
What’s Next?
Volato intends to continue exploring further opportunities in AI infrastructure, AI software, data infrastructure, compute, and power generation. Additional details will be disclosed through the company’s filings, including a Current Report on Form 8-K. Investors should monitor for further updates, especially regarding the closing of this investment and any material developments in acquisition or merger discussions.
About Volato Group
Volato Group, Inc. is a technology company specializing in scalable software and data solutions to improve the reliability and intelligence of high-stakes business decisions. Its Parslee Document Intelligence platform enhances large language models with deterministic structure and auditability for complex documents, such as contracts and SEC filings. For more information, visit www.flyvolato.com.
Disclaimer
This article contains forward-looking statements based on current expectations, assumptions, and projections. Actual results may differ materially due to various risks, including the possibility that proposed transactions may not be completed, regulatory or market hurdles, and other factors outlined in Volato’s public SEC filings. The company undertakes no obligation to update forward-looking statements except as required by law. This article does not constitute an offer or solicitation to buy or sell securities.
